权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Human centred design of an affordable insulin delivery innovation for people with diabetes in developing countries

以人为本的设计，为发展中国家的糖尿病患者提供负担得起的胰岛素输送创新

基本信息

批准号：
74417
负责人：
金额：
$ 7.6万
依托单位：
3B ADVISORY LIMITED
依托单位国家：
英国
项目类别：
CR&D Bilateral
财政年份：
2020
资助国家：
英国
起止时间：
2020 至无数据
项目状态：
已结题

来源：
https://gtr.ukri.org/projects?ref=74417
关键词：
Human centred design affordable insulin

项目摘要

3B Impact works with innovative companies to scale solutions to global challenges. It is working with diabeties device experts at GO-Pen Aps and experienced practitioners at Médecins Sans Frontières UK to commercialise an innovative insulin delivery system, designed specifically for diabetics on low incomes in developing countries, such as Malaysia.Insulin delivery systems are designed for affluent markets. While the rich can afford insulin pens, 13 million poor people with diabetes take insulin through 3-4 daily injections using syringes. These are not fit for purpose. Syringes make it harder to deliver correct dosages leading to complications including blindness, amputations and death, and produce significant amounts of hazardous waste. Single use syringes are often used multiple times, risking infection.GO-Pen's solution eliminates the need for syringes, is safer and more affordable. The benefits are:1. a quicker, more discrete injection;2. precise dosing;3. less training needed from healthcare professionals;4. easier to use leading to better treatment;5. lower risk of complications;6. reduced cost; and7. reduced hazardous waste.Success depends on ensuring users want to use the GO-Pen and that it improves how insulin is used, the focus of this project.

3B Impact与创新公司合作，扩展解决方案以应对全球挑战。该公司正在与Go-Pen APS的糖尿病设备专家和英国无国界医生的经验丰富的从业者合作，将一种创新的胰岛素输送系统商业化，该系统专门为马来西亚等发展中国家的低收入糖尿病患者设计。胰岛素输送系统是为富裕市场设计的。虽然富人买得起胰岛素笔，但1300万贫穷的糖尿病患者每天使用注射器注射3-4次胰岛素。这些东西不合乎目的。注射器使提供正确剂量变得更加困难，导致包括失明、截肢和死亡在内的并发症，并产生大量危险废物。一次性使用的注射器经常被多次使用，有感染的风险。GO-Pen的解决方案消除了对注射器的需求，更安全，更实惠。好处是：1.更快、更离散的注射；2.精确的剂量；3.需要医疗专业人员的更少培训；4.更容易使用，从而获得更好的治疗；5.更低的并发症风险；6.降低成本；以及7.减少有害浪费。成功取决于确保用户想要使用Go-Pen，并改善胰岛素的使用方式，这是本项目的重点。